Kiromic BioPharma Inc. (NASDAQ:KRBP) traded at $0.21 at close of the session on Tuesday, 01/24/23, made a downward move of -24.08% on its previous day’s price.
Looking at the stock we see that its previous close was $0.28 and the beta (5Y monthly) reads -0.26 with the day’s price range being $0.16 – $0.2617. In terms of its 52-week price range, KRBP has a high of $1.23 and a low of $0.15. The company’s stock has gained about 19.90% over that past 30 days.
Kiromic BioPharma Inc. has a market cap of $3.76 million and is expected to release its quarterly earnings report on Mar 09, 2023 – Mar 13, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.56, with the EPS growth for the year raised at -$2.15 for 2022 and -$2.37 for next year. These figures represent 4.90% and -10.20% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the KRBP stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 7.76% off its SMA20 and -8.57% from its 50-day simple moving average. The RSI (14) is pointing at 49.29 while the volatility over the past week is 26.86% and jumps to 21.09% over the past one month.
Coming back to Kiromic BioPharma Inc. (NASDAQ:KRBP), we note that the average 3-month trading volume was 169.16K, while that of the preceding 10-day period stands at 0.66 million. Current shares outstanding are 15.84 million.
The insiders hold 6.60% of the company’s shares while institutions hold 1.70%. The data shows that short shares as of Oct 13, 2022, stood at 0.6 million at a short ratio of 0.36. This represents a 3.81% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 0.5 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 16.38% up in year-to-date price movement.